Literature DB >> 4932833

Genesis of hyperparathyroidism.

E Reiss, J M Canterbury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4932833     DOI: 10.1016/0002-9343(71)90123-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  17 in total

1.  [Surgical aspects of secondary hyperparathyroidism (author's transl)].

Authors:  H D Röher; R Wahl
Journal:  Langenbecks Arch Chir       Date:  1976-12-22

2.  Diseases of the urinary system. renal osteodystrophy.

Authors:  D J Hosking
Journal:  Br Med J       Date:  1977-07-09

3.  [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].

Authors:  G Offermann; K Schaefer; A Schulz; G Delling
Journal:  Klin Wochenschr       Date:  1976-07-01

4.  Different responses between the upper and the lower parathyroid gland in a state of secondary hyperfunction. A study on chronic renal failure by morphometry and nuclear DNA analysis.

Authors:  H Matsushita
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells.

Authors:  C Juhlin; J Rastad; L Klareskog; L Grimelius; G Akerström
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 6.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

Review 7.  Diagnosis and treatment of hypercalcaemia.

Authors:  L Watson
Journal:  Br Med J       Date:  1972-04-15

Review 8.  Role of parathyroid hormone in the pathogenesis of the uremic manifestations.

Authors:  S G Massry
Journal:  Klin Wochenschr       Date:  1979-10-01

9.  Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.

Authors:  D A Goldstein; L A Chui; S G Massry
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.

Authors:  F L Coe; J M Canterbury; J J Firpo; E Reiss
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.